EFTA01493850Set 10
2013-01-311p184w
ZOETIS INC 28.00 25,000.000 650,000.00 850,000.00
98978V-10.3 ZTS
Total US Large Cap Equity $2,306,620.90 $2,32602.10 ($21,271.20) $0.00 0.00%
US Small Cap Equit
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01493850.pdf
EFTA01493802Set 10
2013-01-311p182w
ZOETIS INC 28.00 25,000.000 850,000.00 850,000.00
98978V-10.3 ZTS
Total US Large Cap Equity $2,306,620.90 $2,32602.10 ($21,271.20) 60.00 0.00%
US Small Cap Equit
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01493802.pdf
EFTA02131300Set 10
2013-08-0610p2,632w
FOSL, HAR, HCN, HSIC,
ICE, IFF, LINTA, PH, ROC, REGN, SE, SRE, TAP, THC, ZTS, ACM, AER, AFSI, AKRX, ALLT, AMRI,
ARCC, ARCO, AYR, BBEP, BCRX, BIP, BLRX
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02131300.pdf
EFTA02090749Set 10
2014-11-187p1,856w
Sausalito)
Analyst/Investor Days: AZN, EFX, PFE, DNR, INGR, LGND, UTEK, TPH, SYNA, MAC, SGI, ZTS,
BEL, NOV, CY
Non-Deal Roadshows: ABM, ACCO, EEFT, EGL, INWK, ISIS, SEIC, SHI, AKRX
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02090749.pdf
EFTA02121389Set 10
2020-11-139p2,210w
NTAP, NVDA, OMEX, POL, PXLW, RFMD, RSO, RUTH, SFUN,
SOI, UBNT, URG, VOD, WYN, ZTS
Shareholder Meetings: CACI, ROIAK, AHPI, BR, PMFG, SWS, WDC, TAX, CDZI, MTRX, NVGN
Equity/Mixed Shelfs
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02121389.pdf
EFTA00306883Set 9
2014-06-027p4,747w
PRGO), Pfizer Inc. (PFE), Sagent Pharmaceuticals (SGNT), Teva Pharmaceuticals (TEVA),
Valeant Pharmaceuticals (VRX), Zoetis (ZTS)
M. Morgan Equity Research Ratings Distribution, as of March 31, 2014
Overweight Neutral Underweight
https://www.justice.gov/epstein/files/DataSet%209/EFTA00306883.pdf
EFTA00598930Set 9
2015-10-025p4,184w
PRGO), Pfizer Inc. (PFE), Sagent
Pharmaceuticals (SGNT), Teva Pharmaceuticals (TEVA), Valeant Pharmaceuticals (VRX), Zoetis (ZTS)
M. Morgan Equity Research Ratings Distribution, as of September 30, 2015
Overweight Neutral Underweight
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598930.pdf
EFTA01087638Set 9
2015-10-015p3,969w
PRGO), Pfizer Inc. (PFE), Sagent
Pharmaceuticals (SGNT), Teva Pharmaceuticals (TEVA), Valeant Pharmaceuticals (VRX), Zoetis (ZTS)
J.P. Morgan Equity Research Ratings Distribution, as of September 30, 2015
Overweight Neutral Underweight
(hold
https://www.justice.gov/epstein/files/DataSet%209/EFTA01087638.pdf
EFTA02145596Set 10
2013-03-087p1,682w
downgrades AVG
• Canaccord downgrades TIF (sell), Compass Pt initiates NNI (buy), BMO initiates ZTS (up)
Europe Key Research:
Nomura downgrade CLN VX, UBS upgrade SDR LN, TECN SW, downgrade UPM1V
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02145596.pdf
nail
_5evt-:, CitC
4OZr1-0%.
\ tc k
—theiloatcl kks C ,s(
can\zro) 'Zts
_40 cv kis ra ke,
Soi,-cuil-A-za S-y,scne
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01728825.pdf
EFTA01087643Set 9
2015-09-307p4,532w
PRGO), Pfizer Inc. (PFE), Sagent
Pharmaceuticals (SGNT), Teva Pharmaceuticals (TEVA), Valeant Pharmaceuticals (VRX), Zoetis (ZTS)
J.P. Morgan Equity Research Ratings Distribution, as ofJune 30, 2015
Overweight Neutral Underweight
(buy) (hold
https://www.justice.gov/epstein/files/DataSet%209/EFTA01087643.pdf